The Justice Department’s Antitrust Division has resumed a targeted Hart-Scott-Rodino review process, an important signal that federal merger scrutiny remains active and potentially more exacting for certain transactions. While this development is not tied to a single headline-grabbing court fight, it matters because the HSR process is the front door to U.S. merger enforcement: changes in how the government screens deals can directly affect closing timelines, regulatory strategy, and overall transaction risk.

The announcement from the U.S. Department of Justice Antitrust Division suggests that parties should expect renewed attention to selected reportable deals during the premerger review stage.

The Justice Department has proposed an antitrust settlement with Willow Bridge Property Company LLC, one of the country’s largest landlords, in a case that underscores a continuing enforcement priority: the use of pricing algorithms and shared competitively sensitive information in rental housing markets.

According to the government, the case centers on allegations that Willow Bridge participated in information sharing and coordination practices affecting apartment rents.

A California-led coalition of 12 states has filed a federal antitrust suit in the Northern District of California seeking to block Paramount’s proposed $110 billion deal involving Warner Bros.

The FTC has announced a significant settlement with Caremark Rx LLC and Zinc Health Services LLC in its insulin-pricing antitrust matter, marking one of the clearest signals yet that pharmacy benefit manager rebate structures remain a top enforcement priority. According to the agency, the deal is designed to reduce patients’ out-of-pocket costs, increase transparency, and curb rebate practices that allegedly contributed to higher insulin list prices.

The proceeding, Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin), is part of the FTC’s broader challenge to how major drug middlemen negotiate formularies, rebates, and placement decisions for high-demand medications.

The Justice Department has announced a proposed antitrust settlement with Willow Bridge, one of the country’s largest landlords, resolving allegations that the company participated in unlawful information-sharing and algorithmic coordination in apartment pricing. While the matter is not a private damages case, it is an important marker in the government’s broader campaign against rent-setting practices that allegedly reduce competition in local housing markets.

The significance of the settlement goes beyond a single landlord.

The Justice Department’s proposed settlement with Willow Bridge Property Company marks another meaningful step in the government’s campaign against alleged algorithmic coordination in rental housing. The case, brought by the Antitrust Division in the Middle District of North Carolina, focuses on whether landlords’ sharing of competitively sensitive information and use of pricing software crossed the line from lawful revenue management into unlawful coordination.

Although the proposed resolution applies specifically to Willow Bridge, its significance is broader.

The Justice Department’s proposed antitrust settlement with Willow Bridge, announced July 6, 2026, is the latest indication that federal enforcers remain focused on alleged coordination in multifamily housing markets — particularly where information sharing and pricing technology intersect.

A federal judge in New York has granted preliminary approval to a revised $38 billion settlement in the long-running interchange-fee litigation against Visa and Mastercard, marking another major milestone in one of the largest antitrust-related civil cases in U.S. history. The case centers on merchant allegations that the card networks and related defendants imposed excessive “swipe fees” and maintained anticompetitive rules that inflated the cost of accepting credit cards.

Preliminary approval is not the end of the road.

OhioHealth has agreed to stop using contract provisions that federal antitrust enforcers said restricted insurers’ ability to guide patients to lower-cost providers, resolving one of two government healthcare competition cases against the system. The settlement is a notable reminder that, even as enforcement priorities shift more broadly in Washington, healthcare remains a sector where regulators continue to scrutinize contracting practices that may limit price competition.

At the center of the dispute were alleged “anti-steering” terms in payer contracts.

The Justice Department’s Antitrust Division has completed its review of Paramount’s proposed acquisition of Warner Bros. and concluded the transaction is not likely to substantially lessen competition. In most deal cycles, that would mark the end of the government review story. Here, it may be the beginning of the litigation story.

According to reports, attorneys general in California, New York, and potentially other states are preparing to challenge the merger anyway.

The Justice Department cleared Paramount’s acquisition of Warner Bros. on June 12, 2026, finding the transaction was unlikely to substantially lessen competition in traditional television markets. But the federal green light may be only the beginning. California, New York, and other states are reportedly preparing their own challenge, creating the prospect of a high-stakes showdown over how aggressively state enforcers can police deals the federal government declines to stop.

That split is what makes this story especially significant.

The Justice Department’s Antitrust Division has required Taiheiyo Cement Corporation and CalPortland Company to divest assets as a condition of moving forward with their acquisition of ready-mix concrete assets from Vulcan Materials Company. Although the matter did not produce a court opinion, it is a notable enforcement action in a sector that sits at the center of public infrastructure, commercial development, and residential construction.

The government’s intervention underscores a familiar antitrust concern: consolidation in highly local markets for essential building materials.

The Justice Department’s Antitrust Division has announced a criminal indictment against four container manufacturing companies and seven executives for an alleged price-fixing conspiracy during the Covid-19 pandemic. Even without all charging details yet public, the case stands out for pairing corporate defendants with individual executive charges in a market tied to essential goods during a period of severe supply-chain disruption.

That combination is important.

As of Sunday, June 7, 2026, the legal landscape is being shaped by a cluster of developments that matter well beyond the headlines. For litigators, in-house teams, and compliance officers, the significance is less about any single ruling and more about how courts and agencies continue to redraw the boundaries of enforcement, liability, and procedural strategy.

Among the most consequential developments are decisions and agency actions affecting administrative power, workplace regulation, antitrust scrutiny, privacy enforcement, and securities oversight.

Antitrust enforcement remained one of the most important U.S. legal developments in the last 24 to 72 hours, with fresh activity in the government’s ongoing campaign against major technology platforms. Recent filings and hearing activity in several headline matters show enforcers moving beyond liability theories and deeper into the remedies phase—where structural relief, business-practice restrictions, and long-term compliance obligations become concrete risks rather than abstract possibilities.

That shift matters.